CTRI/2023/11/060210
尚未招募
4 期
Clinical evaluation of retinal perfusion when performing cataract surgery with low vs high preset IOP in eyes with diabetic retinopathy - NI
Alcon Laboratories USA0 个研究点目标入组 0 人待定
概览
- 阶段
- 4 期
- 干预措施
- 未指定
- 疾病 / 适应症
- Health Condition 1: H36- Retinal disorders in diseases classified elsewhere
- 发起方
- Alcon Laboratories USA
- 状态
- 尚未招募
- 最后更新
- 2年前
概览
简要总结
暂无简介。
研究者
入排标准
入选标准
- •Age\-related cataract with coexisting diabetic retinopathy (mild, moderate nonproliferative diabetic retinopathy with or without diabetic retinopathy)
排除标准
- •Proliferative diabetic retinopathy with tractional disease or proliferative vitreoretinopathy
- •Prior ocular trauma or surgery
结局指标
主要结局
未指定
相似试验
尚未招募
不适用
Evaluation of retinal vascular function in patients with vitreoretinal disordersDiabetic retinopathy, Retinal vein occulusionJPRN-UMIN000040294ihon University40
已完成
不适用
Evaluation of intra- and transretinal blood flow in Retinal Angiomatous Proliferation detected with phase-resolved Optical Coherence Tomography before and after treatmentRAP10047060NL-OMON45004Oogziekenhuis Rotterdam30
尚未招募
不适用
Assessment of ocular blood flow alterations in response to intraocular pressure elevation with Laser speckle flowgraphyHealthy volunteersJPRN-UMIN000026202Tohoku University Graduate School of Medicine, Department of Ophthalmology20
已完成
不适用
The Validity of Retinal Blood Flow Measurements During Hyperoxia in Humans Using Fourier Domain Color Doppler Optical Coherence Tomography (CDOCT)HealthyNCT00431600Medical University of Vienna12
Unknown
不适用
Comparison of optic nerve perfusion after pan retinal photocoagulation (PRP) versus anti vascular endothelial growth factor (antiVEGF) injection for treatment of high risk proliferative diabetic retinopathy(PDR)Eye DiseasesPaediatricsPACTR202206535473146Ain shams university hospital50